Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer J ; 30(2): 71-78, 2024.
Article in English | MEDLINE | ID: mdl-38527259

ABSTRACT

ABSTRACT: This review outlines the most up-to-date metastatic melanoma treatment recommendations and relevant risks for patients with solid organ transplants, patients with renal dysfunction, and patients with preexisting autoimmune conditions. These specific treatment populations were excluded from the original clinical trials, which studied immune checkpoint inhibitors and BRAF/MEK inhibitors in the advanced melanoma setting. We have synthesized the current body of literature, mainly case series and retrospective analyses, to reflect the evidence for the treatment of these special patient populations at present.


Subject(s)
Melanoma , Humans , Melanoma/drug therapy , Retrospective Studies , Immunotherapy , Protein Kinase Inhibitors/adverse effects , Immune Checkpoint Inhibitors/therapeutic use , Proto-Oncogene Proteins B-raf/therapeutic use
2.
Nature ; 619(7969): 357-362, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37286606

ABSTRACT

Physicians make critical time-constrained decisions every day. Clinical predictive models can help physicians and administrators make decisions by forecasting clinical and operational events. Existing structured data-based clinical predictive models have limited use in everyday practice owing to complexity in data processing, as well as model development and deployment1-3. Here we show that unstructured clinical notes from the electronic health record can enable the training of clinical language models, which can be used as all-purpose clinical predictive engines with low-resistance development and deployment. Our approach leverages recent advances in natural language processing4,5 to train a large language model for medical language (NYUTron) and subsequently fine-tune it across a wide range of clinical and operational predictive tasks. We evaluated our approach within our health system for five such tasks: 30-day all-cause readmission prediction, in-hospital mortality prediction, comorbidity index prediction, length of stay prediction, and insurance denial prediction. We show that NYUTron has an area under the curve (AUC) of 78.7-94.9%, with an improvement of 5.36-14.7% in the AUC compared with traditional models. We additionally demonstrate the benefits of pretraining with clinical text, the potential for increasing generalizability to different sites through fine-tuning and the full deployment of our system in a prospective, single-arm trial. These results show the potential for using clinical language models in medicine to read alongside physicians and provide guidance at the point of care.


Subject(s)
Clinical Decision-Making , Electronic Health Records , Natural Language Processing , Physicians , Humans , Clinical Decision-Making/methods , Patient Readmission , Hospital Mortality , Comorbidity , Length of Stay , Insurance Coverage , Area Under Curve , Point-of-Care Systems/trends , Clinical Trials as Topic
SELECTION OF CITATIONS
SEARCH DETAIL